Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies - Test2 - elhamkhani - TriplyDB

Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies

Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies

http://www.wikidata.org/entity/Q24647838

about

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes Management of gastric and duodenal neuroendocrine tumors Endocrine neoplasms in familial syndromes of hyperparathyroidism Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas Elusive liver factor that causes pancreatic α cell hyperplasia: A review of literature Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management Pancreatic endocrine neoplasms: a current update on genetics and imaging.Surgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 Zollinger-Ellison Syndrome Associated with von Recklinghausen Disease: Case Report and Literature Review Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes Hereditary pancreatic cancer: related syndromes and clinical perspective.Recent standardization of treatment strategy for pancreatic neuroendocrine tumors.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.Insulinoma and anaesthetic implications Mechanism of acid hypersecretion post curative gastrinoma resection Neuroendocrine tumors of the small bowels are on the rise: Early aspects and management.Zollinger-Ellison syndrome: classical considerations and current controversies.Everolimus for advanced pancreatic neuroendocrine tumors.Quality of life, resource utilisation and health economics assessment in advanced neuroendocrine tumours: a systematic review.Update on pancreatic neuroendocrine tumors.Practical management and treatment of pancreatic neuroendocrine tumors.Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas Exploring the tumors of multiple endocrine neoplasia type 1 in mouse models for basic and preclinical studies Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinica Safety and efficacy of everolimus in adult patients with neuroendocrine tumors.Multiple Endocrine Neoplasia: Genetics and Clinical Management.PTCH 1 staining of pancreatic neuroendocrine tumor (PNET) samples from patients with and without multiple endocrine neoplasia (MEN-1) syndrome reveals a potential therapeutic target.Bioassay and Scanning Electron Microscopic Observations Reveal High Virulence of Entomopathogenic Fungus, Beauveria bassiana, on the Onion Maggot (Diptera: Anthomyiidae) Adults.Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors.A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1 Pharmacotherapy of Zollinger-Ellison syndrome.Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.A new double substitution mutation in the MEN1 gene: a limited penetrance and a specific phenotype.Genetics of pancreatic neuroendocrine tumors: implications for the clinic.

P2860

Q24603675-1176FF36-5F31-4469-A849-29470CBD7D17 Q26738541-61CEC700-107C-4F94-9ED1-771AC63D01BB Q26747174-2A17C83A-3089-440D-87C5-2F38AB9B6CC8 Q26752757-443AA1E9-8E3B-40CF-AE45-C102F75E66BB Q26776169-34095919-AEB6-420D-A3C3-BDC92684C448 Q26795597-DF96C67B-8807-4621-ACBF-FCCB819E8283 Q26852418-5DD1A0FE-20A0-41F2-872F-917E969AF1AD Q27026980-D0151286-2EC4-42F6-8629-06ADCA58B8F6 Q28069439-233EB59F-18BD-412E-8BC5-BEC037F3F4C7 Q28290833-C7E6D8DA-9907-4D10-8371-F1E7EA988A99 Q30475253-862CA7A0-DFC9-45CA-AC84-0CF3E8DF1ABA Q33851085-CE0DC825-7E95-4FAD-AE64-04486CBE6390 Q34155032-62769C94-248E-45B8-8B50-9CF78F73684C Q34248466-6D912F1F-11A8-4F44-894E-4A0EA67B422C Q34304877-197DEC22-2AE9-4DE9-868C-4E9950B492EB Q34345074-4BEF978C-6131-4501-8000-BD882992C185 Q34389590-11861219-A390-4F4E-86F9-B519DA607A7A Q34390574-95357E71-D9AA-4BFB-991D-33823E67BB2A Q34399809-36D95A47-814A-4270-B3A9-2CFCFAE1DBB6 Q34400151-41F8A541-C347-4BA2-8E2A-7127F0B9CE70 Q34453043-B6CD2457-9B7B-400E-B160-E9C0DB8AFBE9 Q34573600-BC02AD05-8B59-4B3A-8A95-B48F9F51E111 Q34650411-2D0ADD10-B475-45D3-BB36-E04422823DC9 Q34965132-C47A0D69-3122-41AD-A8EB-6A0077C62176 Q35001777-21BD7B00-DDE0-4791-A60B-16FA1C3231FA Q35082433-0F031A2A-7F44-4D5D-A58F-A38301071ECB Q35640506-AFCA37E2-2C56-4468-AC3A-35514D01D2C3 Q35669138-86326E7E-18A2-485E-80ED-AF6CF3D0746F Q36063577-401A8DC3-3819-40DB-AFC9-632C0B5172C3 Q36214629-A561CFED-085A-4814-8409-5EE63D277EED Q36227095-202E7F8E-BA39-479E-96D3-DC375D0E9F1E Q36351873-F53E6EEC-C844-4B09-A01B-7BF36FCDA741 Q36377417-FE722BD2-C47C-4DCF-92FB-05A2E8E9E8B5 Q36535847-BF5A64B8-78E1-4269-B7F6-6DC315ED6850 Q36632665-9EE5DA9A-8EA5-431D-8A29-9CDE84616561 Q36770359-06307751-5050-443B-8FB5-E1ED21CEF5C9 Q36843996-829EDF22-6795-4C7A-BC04-D315FA5DF100 Q36849357-AAE5B505-F45A-4FC7-A9DE-4F0CDE3E9750 Q36856421-95E915D4-3302-4B5F-B7E9-0DE09CF8F6DB Q36960581-8F3EBF46-8C4C-4F55-A440-EF61B0125DC5

P2860

Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies

http://www.wikidata.org/entity/Q24647838

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Inherited pancreatic endocrine ...... management, and controversies

@ast

Inherited pancreatic endocrine ...... management, and controversies

@en

Inherited pancreatic endocrine ...... management, and controversies

@nl

type

label

Inherited pancreatic endocrine ...... management, and controversies

@ast

Inherited pancreatic endocrine ...... management, and controversies

@en

Inherited pancreatic endocrine ...... management, and controversies

@nl

prefLabel

Inherited pancreatic endocrine ...... management, and controversies

@ast

Inherited pancreatic endocrine ...... management, and controversies

@en

Inherited pancreatic endocrine ...... management, and controversies

@nl

P1433

Q24647838-EF80EEEE-E9B6-4EBE-8A00-674711612F25

P1476

Q24647838-EF371E4E-B35E-4652-9B45-6F5384E11646

P2093

Q24647838-234B0A94-72E5-4B57-8AA0-683D52C2081C

Q24647838-4A1934D3-6FCE-4FD9-89D1-6672711B2073

Q24647838-DBD2A286-29A2-45D0-BE30-40475C9DBF18

Q24647838-E751EF5B-A4B1-430B-8809-BCE6BDB70430

P2860

Q24647838-04579060-2D72-4066-B1C7-78BFE881B2B0

Q24647838-0669A00B-9A05-4030-AF41-707FEC412DA8

Q24647838-08786F3C-A586-4256-B3F5-1D8CED1FED63

Q24647838-0936D202-813C-46B1-8E32-85B37BC6B2AD

Q24647838-097C8511-B22B-4401-A868-21939012FA75

Q24647838-0C5E259F-C6BD-439D-8D3F-D56BA4748D8E

Q24647838-0C71B3F3-CA0B-43D1-BAFC-96E8064CACCA

Q24647838-0DB9D606-9629-457A-A0B2-1A8AF989E9A5

Q24647838-0F284793-E7CB-408A-A72C-46F35405F3EF

Q24647838-106FEF06-7C5D-4E79-A9C7-C0BD55CFEB0F

P304

Q24647838-C00BE996-8262-4E8C-9C01-6AE92F03D033

P31

Q24647838-37366ADE-B91D-4369-BB6D-186796401D14

P3181

Q24647838-F7E542BD-254D-4622-9880-C15EE77AC189

P356

Q24647838-8CFFB6D2-BC9C-4091-B89B-97B2DEAD6A93

P407

Q24647838-C7B5DC83-A98A-4869-B6B2-AE7767BA4CD3

P433

Q24647838-DB549130-A8D0-41D6-8489-B4DDA8378A06

P478

Q24647838-5D768BDC-D68A-445D-B7F3-4CD54A8785DB

P577

Q24647838-F43688DC-F477-4560-9553-7F45619C89D2

P5875

Q24647838-109A8C17-B4B0-42FE-A6CE-1B400163B917

P698

Q24647838-BC4BFC45-0E91-4D4B-9011-F019B8BFAED2

P921

Q24647838-295F3326-49B6-4CA1-821C-F831C15C588A

Q24647838-bc5f7369-7d1d-4f6c-a2f0-73f45f6e2e2b

P932

Q24647838-00523FE8-21AC-4D21-B21B-CA0C25346965

P3181

P356

P1433

P1476

Inherited pancreatic endocrine ...... management, and controversies

@en

P2093

David B Bingham

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Norton

http://www.w3.org/2001/XMLSchema#string

Marc J Berna

http://www.w3.org/2001/XMLSchema#string

Robert T Jensen

http://www.w3.org/2001/XMLSchema#string

P2860

Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23

Menin interacts directly with the homeobox-containing protein Pem

Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2

Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain

Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response

Direct binding of DNA by tumor suppressor menin

Multiple tumor suppressor pathways negatively regulate telomerase

Menin associates with FANCD2, a protein involved in repair of DNA damage

Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus

Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors

P304

1807-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

844511

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/CNCR.23648

http://www.w3.org/2001/XMLSchema#string

P407

P433

7 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23263001

http://www.w3.org/2001/XMLSchema#string

P698

18798544

http://www.w3.org/2001/XMLSchema#string

P921

P932

2574000

http://www.w3.org/2001/XMLSchema#string